Evidence map›Paper›PMID 24967878›Full record

ArticlePloS one2014

Optically measured microvascular blood flow contrast of malignant breast tumors.

Regine Choe, Mary E Putt, Peter M Carlile, Turgut Durduran, Joseph M Giammarco, David R Busch, Ki Won Jung, Brian J Czerniecki, Julia Tchou, Michael D Feldman and 5 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06360809 (Prehabilitation Exercise Program in Breast Cancer), which is not on this map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06360809 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Prehabilitation Exercise Program in Breast Cancer: Effects on Quality of Life and Tumor Microenvironment (PEP_BC)

TypeinterventionalSponsorInstitut Nacional d'Educacio Fisica de CatalunyaRan2024 to 2025Enrolled76ConditionsBreast CancerArmsPrehabilitation exercise program
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Regine ChoeDepartment of Biomedical Engineering, University of Rochester, Rochester, New York, United States of America.
Mary E PuttDepartment of Biostatistics & Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Peter M CarlileDepartment of Biomedical Engineering, University of Rochester, Rochester, New York, United States of America.
Turgut DurduranICFO- Institut de Ciències Fotòniques, Castelldefels (Barcelona), Spain.
Joseph M GiammarcoDepartment of Astronomy & Physics, Eastern University, St. Davids, Pennsylvania, United States of America.
David R BuschDepartment of Physics & Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America; The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
Ki Won JungDepartment of Biomedical Engineering, University of Rochester, Rochester, New York, United States of America.
Brian J CzernieckiDepartment of Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Julia TchouDepartment of Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Michael D FeldmanDepartment of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Carolyn MiesDepartment of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Mark A RosenDepartment of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Mitchell D SchnallDepartment of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Angela DeMicheleDepartment of Medicine (Hematology/Oncology), Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Arjun G YodhDepartment of Physics & Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Hospital of the University of Pennsylvania · USUniversity of Rochester · USUniversity of Pennsylvania · USChildren's Hospital of Philadelphia · USEastern University · USInstitute of Photonic Sciences · ES

Funding

WORKSHOP ON ADVANCES IN MUSCULOSKELETAL MRIP41RR002305 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI SONG, HEE KWON · 1985 to 2011
$14.7M
Training in Molecular Therapeutics for Pediatric CardiologyT32HL007915 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI Robert J Levy, JOSEPH W ROSSANO · 1999 to 2026
$13.4M
Diffuse Optics for Acute Stroke ManagementR01NS060653 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI YODH, ARJUN G. · 2008 to 2018
$5.5M
Multi-Spectral Parallel-Plate Diffuse Optical Breast TomographyR01EB002109 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI YODH, ARJUN G. · 2003 to 2012
$3.9M
Augmented Physiologic Monitoring to Predict Brain Injury in Infants with CHDR01NS072338 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI LICHT, DANIEL JACQUES · 2011 to 2015
$1.7M
In Vivo Cancer Therapy Monitoring with Diffuse Optical MethodsR00CA126187 · NCI · UNIVERSITY OF ROCHESTER · PI CHOE, REGINE · 2011 to 2013
$710k
In Vivo Cancer Therapy Monitoring with Diffuse Optical MethodsK99CA126187 · NCI · UNIVERSITY OF PENNSYLVANIA · PI CHOE, REGINE · 2008 to 2009
$164k
NCI NIH HHS K99 CA126187NCI NIH HHS R00 CA126187NCRR NIH HHS P41 RR002305NCRR NIH HHS P41-RR002305NHLBI NIH HHS HL007915NHLBI NIH HHS T32 HL007915NIBIB NIH HHS R01 EB002109NIBIB NIH HHS R01-EB002109NINDS NIH HHS R01 NS060653NINDS NIH HHS R01 NS072338
6 · The paper itself

Abstract

Microvascular blood flow contrast is an important hemodynamic and metabolic parameter with potential to enhance in vivo breast cancer detection and therapy monitoring. Here we report on non-invasive line-scan measurements of malignant breast tumors with a hand-held optical probe in the remission geometry. The probe employs diffuse correlation spectroscopy (DCS), a near-infrared optical method that quantifies deep tissue microvascular blood flow. Tumor-to-normal perfusion ratios are derived from thirty-two human subjects. Mean (95% confidence interval) tumor-to-normal ratio using surrounding normal tissue was 2.25 (1.92-2.63); tumor-to-normal ratio using normal tissues at the corresponding tumor location in the contralateral breast was 2.27 (1.94-2.66), and using normal tissue in the contralateral breast was 2.27 (1.90-2.70). Thus, the mean tumor-to-normal ratios were significantly different from unity irrespective of the normal tissue chosen, implying that tumors have significantly higher blood flow than normal tissues. Therefore, the study demonstrates existence of breast cancer contrast in blood flow measured by DCS. The new, optically accessible cancer contrast holds potential for cancer detection and therapy monitoring applications, and it is likely to be especially useful when combined with diffuse optical spectroscopy/tomography.

Indexed as

Regional Blood FlowAdultBreast NeoplasmsCase-Control StudiesFemaleHumansLaser-Doppler FlowmetryMicrovesselsMiddle Aged

Identifiers

PMID24967878
PMCPMC4072684
OpenAlexW1982499849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.